Cargando…

Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy

Detalles Bibliográficos
Autores principales: Yin, Lin, Li, Na, Jia, Weihua, Wang, Nuoqi, Liang, Meidai, Shang, Jiamin, Qiang, Guifen, Du, Guanhua, Yang, Xiuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126497/
https://www.ncbi.nlm.nih.gov/pubmed/35605093
http://dx.doi.org/10.1002/ctm2.879
_version_ 1784712143741911040
author Yin, Lin
Li, Na
Jia, Weihua
Wang, Nuoqi
Liang, Meidai
Shang, Jiamin
Qiang, Guifen
Du, Guanhua
Yang, Xiuying
author_facet Yin, Lin
Li, Na
Jia, Weihua
Wang, Nuoqi
Liang, Meidai
Shang, Jiamin
Qiang, Guifen
Du, Guanhua
Yang, Xiuying
author_sort Yin, Lin
collection PubMed
description
format Online
Article
Text
id pubmed-9126497
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91264972022-05-25 Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy Yin, Lin Li, Na Jia, Weihua Wang, Nuoqi Liang, Meidai Shang, Jiamin Qiang, Guifen Du, Guanhua Yang, Xiuying Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-05-23 /pmc/articles/PMC9126497/ /pubmed/35605093 http://dx.doi.org/10.1002/ctm2.879 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Yin, Lin
Li, Na
Jia, Weihua
Wang, Nuoqi
Liang, Meidai
Shang, Jiamin
Qiang, Guifen
Du, Guanhua
Yang, Xiuying
Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
title Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
title_full Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
title_fullStr Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
title_full_unstemmed Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
title_short Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
title_sort antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126497/
https://www.ncbi.nlm.nih.gov/pubmed/35605093
http://dx.doi.org/10.1002/ctm2.879
work_keys_str_mv AT yinlin antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT lina antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT jiaweihua antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT wangnuoqi antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT liangmeidai antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT shangjiamin antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT qiangguifen antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT duguanhua antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy
AT yangxiuying antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy